🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Response and Content Removal

According to the social media company, the service has taken down problematic material and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for preparing or administering at residence.

Within moments of joining one group, a vendor shared contact information, where most purchases occur. The seller sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients injured by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly significant medical dangers”.